US 12,144,974 B2
Control device for an implantable heart pump
Michael Frischke, Rangsdorf (DE); and Sebastian Kallenbach, Kassel (DE)
Assigned to Berlin Heart GmbH, Berlin (DE)
Appl. No. 16/468,938
Filed by Berlin Heart GmbH, Berlin (DE)
PCT Filed Dec. 13, 2017, PCT No. PCT/EP2017/082687
§ 371(c)(1), (2) Date Dec. 3, 2019,
PCT Pub. No. WO2018/109038, PCT Pub. Date Jun. 21, 2018.
Claims priority of application No. 16204167 (EP), filed on Dec. 14, 2016.
Prior Publication US 2020/0222605 A1, Jul. 16, 2020
Int. Cl. A61M 60/165 (2021.01); A61M 60/148 (2021.01); A61M 60/178 (2021.01); A61M 60/183 (2021.01); A61M 60/216 (2021.01); A61M 60/411 (2021.01); A61M 60/538 (2021.01); A61M 60/873 (2021.01); A61M 60/876 (2021.01)
CPC A61M 60/148 (2021.01) [A61M 60/178 (2021.01); A61M 60/183 (2021.01); A61M 60/216 (2021.01); A61M 60/411 (2021.01); A61M 60/538 (2021.01); A61M 60/873 (2021.01); A61M 60/876 (2021.01); A61M 2205/16 (2013.01); A61M 2205/18 (2013.01); A61M 2205/3365 (2013.01); A61M 2205/3523 (2013.01); A61M 2205/8206 (2013.01)] 16 Claims
OG exemplary drawing
 
1. A control device configured for controlling an implantable heart pump, the control device comprising:
an implantable first control unit, which in a main operating state is electrically connectable to the heart pump controlled by the control device, the implantable first control unit configured to control operating parameters of the heart pump;
an interface electrically connectable to the first control unit for a wireless, transcutaneous data transmission and/or for a wireless, transcutaneous energy transmission between the first control unit and an extracorporeal control unit provided for extracorporeal use;
an implantable second control unit, which in an auxiliary operating state is electrically connectable to the heart pump, the implantable second control unit configured to control the operating parameters of the heart pump, wherein the auxiliary operating state operates at a lower power than the main operating state;
an implantable switch electrically connectable to the first control unit and the second control unit, the implantable switch configured to switch between the main operating state and the auxiliary operating state; and
a single housing enclosing the first control unit, the second control unit, and the implantable switch, wherein the housing comprises a biocompatible material for an outer surface.